Trial Profile
A clinical trial to investigate the pharmacokinetic interaction of multiple doses of extended-release niacin/laropiprant on multiple doses of simvastatin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Laropiprant (Primary) ; Niacin (Primary) ; Niacin/laropiprant (Primary) ; Simvastatin (Primary)
- Indications Lipid metabolism disorders
- Focus Pharmacokinetics
- 30 Dec 2015 New trial record